DUBLIN, April 17,
2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will
host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m.
BST) on Wednesday, May 1, 2024
to discuss the company's first quarter financial results.
The webcast player and accompanying slides may be accessed on
the Investors section of Alkermes' website at www.alkermes.com. The
conference call may be accessed by dialing +1 877 407 2988 for U.S.
callers and +1 201 389 0923 for international callers. A replay of
the webcast will be available approximately two hours after the
completion of the event and may be accessed by visiting Alkermes'
website.
About Alkermes plc
Alkermes plc is a global biopharmaceutical company that seeks to
develop innovative medicines in the field of neuroscience. The
company has a portfolio of proprietary commercial products for the
treatment of alcohol dependence, opioid dependence, schizophrenia
and bipolar I disorder, and a pipeline of clinical and preclinical
candidates in development for neurological disorders. Headquartered
in Dublin, Ireland, Alkermes has a
research and development center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more
information, please visit Alkermes' website at
www.alkermes.com.
Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402
View original content to download
multimedia:https://www.prnewswire.com/news-releases/alkermes-to-report-first-quarter-financial-results-on-may-1-2024-302119806.html
SOURCE Alkermes plc